BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30458457)

  • 1. High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.
    Liu LB; Huang J; Zhong JP; Ye GL; Xue L; Zhou MH; Huang G; Li SJ
    Med Sci Monit; 2018 Nov; 24():8383-8390. PubMed ID: 30458457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
    Qi W; Shao F; Huang Q
    Med Sci Monit; 2017 Dec; 23():6012-6018. PubMed ID: 29257799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Coiled-Coil Domain-Containing Protein 34 (CCDC34) and its Correlation with Angiogenesis in Esophageal Squamous Cell Carcinoma.
    Hu DD; Li PC; He YF; Jia W; Hu B
    Med Sci Monit; 2018 Feb; 24():698-705. PubMed ID: 29397026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
    Meng F; Tan S; Liu T; Song H; Lou G
    Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer.
    Song Z; Lin Y; Ye X; Feng C; Lu Y; Yang G; Dong C
    Med Sci Monit; 2016 Nov; 22():4475-4481. PubMed ID: 27866212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
    Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
    Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
    Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
    Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
    Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
    Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
    World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
    Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
    Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.
    Geng W; Liang W; Fan Y; Ye Z; Zhang L
    Mol Med Rep; 2018 Jan; 17(1):465-473. PubMed ID: 29115580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinicopathological significance of hematopoietic pre-B cell leukemia transcription factor-interacting protein in cervical carcinoma.
    Wang Y; Li D; Liu Y; Tian S; Chen X
    Pathol Res Pract; 2018 Sep; 214(9):1340-1344. PubMed ID: 30033330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
    Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
    QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
    Zeng L; Sun X
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.